Nicaragua has granted a Hong Kong company the right to build a $40 billion interoceanic canal. Slideshow
India's Ranbaxy launches acne drug in US
(Reuters) - Ranbaxy Laboratories Ltd, India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.
The drug is in-licensed from Cipher Pharmaceuticals Inc, said Ranbaxy, controlled by Japan's Daiichi Sankyo Co, on Monday.
(Reporting by Kaustubh Kulkarni in Mumbai)
- Tweet this
- Share this
- Digg this